Pro Medicus Limited (ASX:PME – Get Free Report) insider Deena Shiff acquired 788 shares of the stock in a transaction dated Friday, February 13th. The stock was acquired at an average cost of A$126.67 per share, with a total value of A$99,815.17.
Pro Medicus Stock Performance
The company has a market capitalization of $29.16 billion, a price-to-earnings ratio of 351.99, a P/E/G ratio of 3.87 and a beta of 0.56. The company has a debt-to-equity ratio of 1.10, a quick ratio of 4.39 and a current ratio of 5.98.
Pro Medicus Dividend Announcement
The business also recently disclosed a Interim dividend, which will be paid on Thursday, March 19th. Stockholders of record on Thursday, March 19th will be given a dividend of $0.32 per share. The ex-dividend date of this dividend is Wednesday, February 25th. This represents a dividend yield of 27.0%. Pro Medicus’s dividend payout ratio is currently 56.41%.
About Pro Medicus
Pro Medicus Limited engages in the development and supply of healthcare imaging software and services to hospitals, diagnostic imaging groups, and other related health entities in Australia, North America, and Europe. The company offers Visage radiology information systems (RIS), a proprietary medical software for practice management, training, installation, professional services, and after-sale support and service products; and Promedicus.net, an e-health platform. It also provides healthcare imaging software that provides radiologists and clinicians with visualization capability for viewing 2-D, 3-D, and 4-D medical images, as well as picture archive and communication system (PACS)/digital imaging software; and integration products.
See Also
- Five stocks we like better than Pro Medicus
- Your Bank Account Is No Longer Safe
- Nvidia CEO Issues Bold Tesla Call
- Buy this Gold Stock Before May 2026
- What a Former CIA Agent Knows About the Coming Collapse
- This $15 Stock Could Go Down as the #1 Stock of 2026
Receive News & Ratings for Pro Medicus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pro Medicus and related companies with MarketBeat.com's FREE daily email newsletter.
